Chronicle Journal: Finance

Investors Snag ACRS Even Cheaper Than Its Secondary Stock Offering

Looking back to 2 days ago, Aclaris Therapeutics Inc (ACRS) priced a 5,483,714 share secondary stock offering at $17.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.